These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7942600)

  • 1. Comparison of the clinic microscopy laboratory with the cytopathology laboratory in the detection of malignant cells in body fluids.
    Ben-Ezra J; Stastny JF; Harris AC; Bork L; Frable WJ
    Am J Clin Pathol; 1994 Oct; 102(4):439-42. PubMed ID: 7942600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the effectiveness of malignancy detection in body fluid examination by the cytopathology and hematology laboratories.
    Kendall B; Dunn C; Solanki P
    Arch Pathol Lab Med; 1997 Sep; 121(9):976-9. PubMed ID: 9302931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of malignancy in body fluids: a comparison of the hematology and cytology laboratories.
    Jerz JL; Donohue RE; Mody RR; Schwartz MR; Mody DR; Zieske AW
    Arch Pathol Lab Med; 2014 May; 138(5):651-7. PubMed ID: 24786122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between the papanicolaou stain and the Wright-Giemsa stain in body fluids: a quality assurance study.
    Gammon RR; Kharazi M; Brandt JT; Keyhani-Rofagha S
    Anal Quant Cytol Histol; 2006 Jun; 28(3):171-4. PubMed ID: 16786726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of the human telomerase RNA component by in situ hybridization in cells from body fluids.
    Nieh S; Chen SF; Fu E; Jan CI; Lee WH
    Acta Cytol; 2005; 49(1):31-7. PubMed ID: 15717752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the clinical microscopy laboratory with the cytopathology laboratory in the detection of malignant cells in body fluids.
    Sulak LE
    Am J Clin Pathol; 1995 Apr; 103(4):533. PubMed ID: 7726151
    [No Abstract]   [Full Text] [Related]  

  • 7. p53 immunostaining as a marker of malignancy in cytologic preparations of body fluids.
    Tiniakos DG; Healicon RM; Hair T; Wadehra V; Horne CH; Angus B
    Acta Cytol; 1995; 39(2):171-6. PubMed ID: 7887063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body fluid microscopy in US laboratories. Data from two College of American Pathologists surveys, with practice recommendations.
    Rabinovitch A; Cornbleet PJ
    Arch Pathol Lab Med; 1994 Jan; 118(1):13-7. PubMed ID: 8285829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of psammoma bodies in serous cavity fluid: a cytopathologic analysis.
    Parwani AV; Chan TY; Ali SZ
    Cancer; 2004 Apr; 102(2):87-91. PubMed ID: 15098252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving Malignancy Detection Rates in Body Fluids Submitted to the Hematology Laboratory for Nucleated Cell Count and Differential: A Quality Improvement Study.
    Zhang ML; Maglantay RJ; Cunningham VL; Goodwin MT; Feeney MW; Keefe J; Tambouret RH; Sohani AR
    Arch Pathol Lab Med; 2021 Feb; 145(2):201-207. PubMed ID: 33501495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluids--good and bad actors: observations from the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology.
    Moriarty AT; Stastny J; Volk EE; Hughes JH; Miller TR; Wilbur DC;
    Arch Pathol Lab Med; 2004 May; 128(5):513-8. PubMed ID: 15086285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analysis and cytopathology of body cavity fluids.
    Stonesifer KJ; Xiang JH; Wilkinson EJ; Benson NA; Braylan RC
    Acta Cytol; 1987; 31(2):125-30. PubMed ID: 3469844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative study of cytomorphology and flow cytometry to detect malignant cells in the body cavity fluid.
    Limvorapitak W; Promsuwicha O; Uauewarakul C
    J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S203-9. PubMed ID: 23590043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel flowcytometry-based approach of malignant cell detection in body fluids using an automated hematology analyzer.
    Ai T; Tabe Y; Takemura H; Kimura K; Takahashi T; Yang H; Tsuchiya K; Konishi A; Uchihashi K; Horii T; Ohsaka A
    PLoS One; 2018; 13(2):e0190886. PubMed ID: 29425230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytology of pleural, peritoneal and pericardial fluids in children. A 40-year summary.
    Wong JW; Pitlik D; Abdul-Karim FW
    Acta Cytol; 1997; 41(2):467-73. PubMed ID: 9100782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Comparison with the diagnostic accuracy on small histologic biopsies.
    Spieler P; Gloor F
    Acta Cytol; 1985; 29(5):753-67. PubMed ID: 2996273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of concurrent ploidy analysis and routine cytopathology in body cavity fluids.
    Sinton EB; Carver RK; Morgan DL; Philpott PJ; Truell JE; Riemann D; Ashton ME
    Arch Pathol Lab Med; 1990 Feb; 114(2):188-94. PubMed ID: 2302036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of clot examination for malignant cells in serous effusions.
    Jalal R; Aftab K; Hasan SH; Pervez S
    Cytopathology; 2009 Aug; 20(4):231-4. PubMed ID: 18627403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. External quality assurance in nongynecologic cytology: The Australasian experience.
    Shield PW; Frost F; Finnimore JL; Wright RG; Cummings MC
    Cancer Cytopathol; 2017 May; 125(5):349-361. PubMed ID: 28241108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Leu M5 (CD 11c) antibody in the cytodiagnosis of body fluids: preliminary results.
    Berena J; Sun NC
    J Clin Lab Anal; 1993; 7(1):19-25. PubMed ID: 8093902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.